Johnson & Johnson (JNJ) Tops Q1 EPS by 9c; Raises FY11 Outlook
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $260.72 -0.05%
Financial Fact:
Interest income: -97M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Interest income: -97M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $1.35, $0.09 better than the analyst estimate of $1.26. Revenue for the quarter came in at $16.2 billion versus the consensus estimate of $15.83 billion.
Raises its FY11 EPS guidance to $4.90-$5, vs. the consensus of $4.83. The company had previously guided to $4.80-$4.90.
Raises its FY11 EPS guidance to $4.90-$5, vs. the consensus of $4.83. The company had previously guided to $4.80-$4.90.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coherent, Inc. (COHR) Tops Q4 EPS by 12c, Offers Guidance
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
- Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot Guidance, Hot ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
